All stories
Jump to date
Thursday, November 19 · 45 stories
- Industry · WI
Sanford Health to Open Virtual-Care Clinic in Pittsville, Wisconsin
Sanford Health is opening a satellite clinic in Pittsville, Wis., on Nov. 30 that pairs virtual provider visits with on-site nursing, pharmacy and lab services, according to the company. The Marshfield-Pittsville Clinic will bring medical and pharmacy services to a community that currently has neither; residents now travel a 50-mile round trip to Marshfield or Wisconsin Rapids for care or prescriptions. At the clinic, a nurse will begin the appointment and connect patients with a remote provider for evaluation and treatment of acute conditions, alongside nurse-only visits, lab collection and an on-site pharmacy. Sanford is remodeling a building on Pittsville School District property for the site, which is part of Sanford's $350 million Virtual Care Initiative launched in 2021 and builds on its January 2025 merger with Marshfield Clinic Health System.
- Industry
CDC Shortens Return-to-Work Rules for Health Care Staff
On September 11, 2026, the CDC released updated guidance on work restrictions for health care personnel exposed to or infected with viral respiratory illnesses, including COVID-19, influenza and RSV, replacing prior COVID-19-specific return-to-work rules with a broader respiratory virus framework, according to a Hall Render client alert. Under the new criteria, staff may return once three days have passed since symptom onset, they have been fever-free for 24 hours without fever-reducing medication, symptoms are improving, and they feel well enough to work, a shorter exclusion than the prior seven-to-ten day COVID-19 standard, and routine pre-return testing is no longer required. Asymptomatic exposed staff generally do not need to be excluded but should use source control through day five after exposure, while infected staff returning to work should continue source control through day seven. The guidance applies to personnel only; CDC's infection-control and transmission-based precaution recommendations for residents and patients have not changed.
- Industry
Becker's Ranks 20 Health Systems by Q3 2026 Operating Margins
Becker's Hospital Review ranks 20 health systems by operating margin for the three months ended September 30, 2026 (some reporting nine-month figures). Tenet Healthcare posted the highest margin at 31.1% on $5.6 billion in revenue, followed by HCA Healthcare at 11.9% on $19.8 billion in revenue. Among nonprofits, BayCare Health System (11.3%) and WVU Health System (9.6%) led, while Kaiser Permanente had the most revenue of any system listed, $34.7 billion, but a 1.4% margin. Allegheny Health Network and Altru Health System each posted operating losses with -3% margins.
- Federal Policy
Senate Judiciary Members Admit Drug Pricing Bills Remain Stalled
At a Senate Judiciary Committee hearing, lawmakers including Sen. John Kennedy (R-La.) acknowledged that Congress has failed to advance drug pricing reform despite Republican control, with Kennedy calling the inaction "zero, zilch, nada." Chairman Chuck Grassley (R-Iowa) noted the committee advanced six bipartisan bills last year targeting drugmaker and PBM practices, but only one, the Affordable Prescriptions for Patients Act, reached the Senate floor; Grassley cited a crowded calendar and industry pushback as likely factors. Witnesses, including Patients for Affordable Drugs Now CEO Merith Basey and Cost Plus Drug Company CEO Alex Oshmyansky, testified that the bills should pass as a package to address patent abuses like product hopping and patent thickets, and that PBM consolidation among CVS Caremark, Express Scripts and OptumRx drives high costs and limits competition.

- Industry · OK
Integris Health Posts $104.4M Operating Income, Advances Risant Deal
Oklahoma City-based Integris Health reported operating income of $104.4 million (2.8% margin) in fiscal 2026, reversing a $22.3 million operating loss the prior year, per its Nov. 17 financial report. Total operating revenue rose to $3.7 billion from $3.3 billion, though results included $92.8 million in FEMA reimbursement revenue; excluding that, operating income was about $11.6 million. Medicaid accounted for 16.2% of gross revenue, up from 15.4%, while commercial payer share declined. Integris signed a definitive agreement Oct. 21 to join Kaiser Permanente's Risant Health, with Risant committing at least $1.3 billion in capital, up to $400 million for transition and integration, and up to $200 million in additional growth capital if performance targets are met; the deal is expected to close in 2027 pending regulatory approval.
- Industry
ECG Roundtable: Health Systems Must Coordinate on Medicaid Eligibility Changes
At Becker's 14th Annual CEO + CFO Roundtable on November 2, ECG Management Consultants strategists John Hasbargen and Orlando Alvarez Jr. led a discussion with health system executives on five premises about the future care delivery network. Among them, Alvarez raised concerns about upcoming Medicaid eligibility changes under the One Big Beautiful Bill Act, including new requirements beginning January 1, 2027, and potential coverage losses as beneficiaries face more frequent renewals and new eligibility requirements. He asked attendees how health systems and FQHCs are collaborating to help patients retain coverage. Participants described proactive outreach, data-sharing partnerships with FQHCs tied to rural health transformation applications, and retraining front-desk staff as case managers, with one noting that patients losing coverage still need care and otherwise show up in the ER as self-pay.
- Industry · PA
Penn Medicine's Q1 Operating Margin Falls to 2.4%
Penn Medicine reported operating income of $87.7 million, a 2.4% operating margin, for the first quarter of fiscal 2027, down from $109.3 million and a 3.3% margin a year earlier, per its Nov. 17 financial report. Total operating revenue rose to $3.6 billion from $3.3 billion, while total operating expenses rose to $3.4 billion from $3.1 billion. Net income fell to $106.3 million from $222.1 million. Managed care accounted for 58% of revenue, up from 57%, and Medicare accounted for 27%, up from 26%, for the three months ended Sept. 30.
- Federal Policy
Congressional Commission Warns US Pharma Depends on China Biotech
The National Security Commission on Emerging Biotechnology, a congressional body, warned in a Nov. 18 brief that China is working to control the pharmaceutical supply chain from manufacturing to drug discovery, and that U.S. drugmakers' growing licensing deals with Chinese biotechs are deepening American dependence. The commission said China published a pharmaceutical-focused follow-on to its 15th Five-Year Plan in September setting 2030 goals for more first-in-class drugs and global sales, and analyzed 57 deals between the 15 largest U.S. drugmakers and 42 Chinese biotechs from January 2023 to October 2026, finding rising up-front payments and escalating deal structures. It pointed to China's October proposal, not yet final, to restrict exports of certain next-generation biopharmaceutical technologies. The brief noted the FDA this month rejected a Chinese-invented lung cancer drug, and that generic drugs rely primarily on India and China for active ingredients while the U.S. accounts for only 12% of production.
- Industry
March of Dimes Gives Vermont Lone A Grade for Maternal Health
March of Dimes released its 2026 report card on maternal and infant health on Nov. 17, grading the U.S. and all 50 states plus the District of Columbia. Vermont was the only state to earn an A, eight states earned a B, and 41 states earned a C, D or F. The U.S. overall earned a D+ for preterm birth for the fifth consecutive year, with nearly 380,000 babies born preterm in 2025 and the preterm birth rate for Black mothers 60% higher than for white and Asian mothers. Early prenatal care improved and maternal mortality declined near pre-pandemic levels, but diabetes, hypertension and low-risk cesarean births all increased; North Carolina was the only state with a statistically significant improvement in infant mortality, while Arkansas, Delaware, Louisiana and Mississippi had some of the highest infant mortality rates.
- Industry
Kaiser Permanente Medicaid SVP Toby Douglas to Depart
Toby Douglas, Kaiser Permanente's senior vice president of Medicaid, announced Nov. 18 that he will leave the organization at the end of 2026, according to his LinkedIn post. Douglas has been with Kaiser for more than eight years and said the health system's Medicaid membership doubled during his tenure to 1.5 million members, with expanded reach to dual-eligible members. He previously served as a commissioner on the Medicaid and CHIP Payment and Access Commission and worked at Centene and the California Department of Health Care Services.
- State Policy · MO
Missouri Delays Paid Family Caregiver Program Amid Budget Uncertainty
Missouri's complex care assistant program, which would train and pay parents, guardians or designees to provide skilled nursing care at home for Medicaid recipients with medical complexities, has stalled for a second year. State lawmakers approved $11 million (including federal matching funds) in each of the past two budgets, but the Department of Health and Senior Services says funding uncertainty makes it unlikely any services will be paid before the next fiscal year. Families like Tommy Smith's and Brinley Atwood's, who rely on Medicaid-authorized home nursing hours they struggle to fill, say the program could offer financial stability and ease a persistent home nursing shortage. The department's fiscal year 2028 budget request includes the same funding level as the current year.

- State Policy · NH
71 NH Disability Providers Risk Medicaid Funding Over Revalidation
As of Wednesday, 71 of more than 100 agencies in New Hampshire's developmental disability care network had not yet revalidated their Medicaid enrollment, according to Jessica Gorton, chief of the state's Bureau of Developmental Services. Federal law requires Medicaid providers to revalidate enrollment every five years to keep receiving funds. Gorton told the state's Developmental Services Quality Council that agencies failing to revalidate by the end of the month will have Medicaid claims suspended, and continued non-compliance could lead to disenrollment as a Medicaid provider. The agencies provide Medicaid-funded services, including in-home care, group homes and day programming, to people with intellectual and developmental disabilities who are legally entitled to such services in New Hampshire. The state has sent email blasts urging agencies to complete revalidation.

- Legal · MA
Baystate Health Sues Commonwealth Care Alliance Over $14M in Unpaid Claims
Baystate Health, based in Springfield, Mass., has sued Commonwealth Care Alliance, alleging the insurer owes nearly $14 million for care already provided and improperly recouped payments in violation of contract terms. The health system will not renew its contract with CCA, a plan serving duals and other members that was acquired by CareSource last year, effective Jan. 1, 2027. Baystate says it pursued legal action after direct efforts to resolve the dispute failed. Patients enrolled in CCA plans will keep in-network access to Baystate providers through Dec. 31, 2026, and the health system will contact affected patients with information on the network change and alternative coverage options.
- Federal Policy
OIG Flags 10 Drug Codes for Medicare Part B Price Substitution
OIG compared Medicare Part B average sales prices (ASPs) with average manufacturer prices (AMPs) for the second quarter of 2026, as required under the Social Security Act. OIG found that 10 drug codes exceeded the AMP by more than 5 percent for two consecutive quarters or three of the previous four quarters, meeting CMS's criteria for price substitution. OIG is sending these 10 drug codes to CMS for review to determine whether to substitute lower payment rates to limit excessive Part B drug payments.
- Legal · RI
OIG Transmits Rhode Island Audit on Opioid Treatment Provider Compliance
HHS OIG transmitted to the Center for Medicaid and CHIP Services a report from the Rhode Island Office of the Auditor General titled "Provider Compliance with Opioid Treatment Program Requirements," issued October 7, 2026. The Rhode Island Office of the Auditor General is responsible for the report and its conclusions; OIG states it is not expressing an opinion on the report or its results. The transmittal memo is dated November 17, 2026.
- Industry · CA
Keck Medicine of USC to Lay Off 77, Including Five Executives
Keck Medicine of USC is laying off 77 employees at its Health Sciences Campus, including five C-suite positions, according to a Nov. 9 WARN notice obtained by Becker's. Affected roles include the chief contracting, managed care and payer relations officer, chief digital and information officer, chief health equity, inclusion and community officer, chief quality officer, and chief nursing officer of USC Care Medical Group, along with IT project managers, clinical informatics staff, directors, managers and analysts. A spokesperson said the cuts aim to streamline administrative structure and expenses, predominantly affecting non-patient-facing roles. Notifications began Oct. 7, and layoffs will occur between Dec. 7 and Jan. 8, 2027, with the system saying additional separations are expected.
- Industry
IDC Survey Finds Few Providers Have Strong AI Oversight
Based on an IDC white paper survey of 501 healthcare executives and revenue cycle leaders, 86.7% of organizations operate three or more AI tools for revenue cycle management, but just 1.2% report strong oversight of AI performance. Only 9.8% use AI to automate half or more of revenue cycle workflows, and just 19.8% are very confident in AI output reliability, with lack of visibility into AI performance and ROI the most-cited governance challenge. About 69% use six or more revenue cycle vendors, and among those with 11 or more vendors, 49.1% reported initial denial rates of 15% or higher versus 11.5% for those with five or fewer. Nearly 85% said they are likely to evaluate an integrated, AI-enabled revenue operating system within 18 months, with existing vendor contracts ranking as the top adoption barrier.
- Industry · NC
Atrium Health to Invest $387M in Levine Children's Hospital Expansion
Atrium Health, part of Advocate Health, announced a $387 million investment in Atrium Health Levine Children's Hospital in Charlotte, North Carolina, according to a Nov. 18 news release. The expansion, the hospital's largest since opening in 2007, will add more than 60 inpatient pediatric beds, more than 40 NICU beds, double emergency department capacity, and bring total capacity to roughly 350 pediatric beds. The project responds to a 43% growth in pediatric inpatient volume in the greater Charlotte area over the past five years and will proceed in phases, with major work between 2027 and 2031.
- Industry
Hospital Panel Details How AI Documentation Tools Protect Case Mix Index
At Becker's 14th Annual CEO + CFO Roundtable, a panel sponsored by clinical AI company Regard discussed how point-of-care AI can prevent diagnoses from being documented in the chart but missed in physician notes, which hurts case mix index, quality scores and revenue. Panelists David Kirk, MD of Regard, Faisal Chawla, MD of Cedars-Sinai, and Gurmeet Sran, MD of Sutter Health shared takeaways including that Cedars-Sinai physicians accept roughly 50-60% of AI-suggested diagnoses, queries fell 6%, and peer-to-peer denial overturns run 70-75% when documentation is centralized. Panelists also warned of "clinical surrender" to AI and urged health systems to question vendors about data use, platform maturity, and trust before adoption. The discussion occurred during a sponsored session on November 3.
- Federal Policy
ASPR Maps US Medical Plants to Spot Supply Chain Risks
The Administration for Strategic Preparedness and Response, an HHS agency, is working with manufacturers and government partners to identify healthcare supply-chain vulnerabilities, according to a Nov. 18 news release. ASPR's Center for Industrial Base Management and Supply Chain is examining dependencies across the medical production chain and mapping manufacturing plants nationwide to find where added domestic capacity could reduce reliance on a single source or vulnerable foreign supplier. The mapping can support earlier coordination with manufacturers and federal partners ahead of events like a forecast hurricane. ASPR has also built resilience measures into federal manufacturing contracts and established the Biopharmaceutical Manufacturing Preparedness Consortium to expand manufacturing capacity and strengthen access to critical supplies.